However, several studies have indicated that prostate-specific antigen (PSA) density is also a reliable indicator of the severity and biopsy outcomes of prostate cancer (PCa) [35], and AI can predict the biopsy outcome of PCa patients [36,37,38]. Here, KLK3 is linked to prostate carcinoma.